Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Friedman Kaplan Seiler Adelman & Robbins is a leading New York-based boutique law firm, founded in 1986, specializing in complex commercial litigation, white collar defense, and corporate legal services. It is not a life sciences, biotech, pharma, CRO, or CMO company, and has no drug development pipeline, modalities, or therapeutic targets. The firm is active, independently operated, and has about 60 attorneys with a total staff of up to 107. Major practice areas include litigation, bankruptcy, real estate, employment, securities, and partnership law, with offices in New York and Newark. Estimated annual revenue is $13.6 million
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Friedman Kaplan Seiler Adelman & Robbins.